| BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed)
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Parent Announcements & Trans-NIH Announcements |
RFA-MH-20-150 |
U24 |
|
| Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 – Clinical Trial Required)
|
|
Tissue Engineering and Regenerative Medicine |
RFA-HL-20-030 |
UG3, UH3 |
|
| Science of Behavior Change (SOBC) Resource and Coordinating Center (U24 Clinical Trial Not Allowed)
|
|
Behavioral & Social Science, Common Fund Programs |
RFA-AG-20-024 |
U24 |
|
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
|
|
Common Fund Programs, Parent Announcements & Trans-NIH Announcements |
RFA-RM-19-011 |
R03 |
|
| In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01)
|
|
Craniofacial & Dental Development, Disorders |
PAR-17-005 |
R01 |
|
| Genetic Susceptibility and Variability of Human Structural Birth Defects (R01)
|
|
Craniofacial & Dental Development, Disorders |
PAR-17-236 |
R01 |
|
| Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)
|
|
Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-18-009 |
R01 |
|
| Global Brain and Nervous System Disorders Research Across the Lifespan (R21)
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
PAR-17-313 |
R21 |
|
| Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
|
|
Global Health, International Research Activities, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
PAR-18-836 |
R21 |
|
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain or Musculoskeletal Trauma (UM1 Clinical Trial Optional)
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
RFA-RM-19-013 |
UM1 |
|
| Pediatric HIV/AIDS Cohort Study (PHACS) 2020 (P01 Clinical Trial Not Allowed)
|
|
HIV/AIDS and Oral Health |
RFA-HD-20-002 |
P01 |
|
| Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
|
|
Bioinformatics, Computational Biology & Data Science, Craniofacial & Dental Development, Disorders |
PAR-17-454 |
R01 |
|
| NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25 Clinical Trial Not Allowed)
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Training & Fellowships |
RFA-NS-20-003 |
R25 |
|
| Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42)
|
|
Common Fund Programs, Small Business (SBIR/STTR), Technology Development |
PA-17-148 |
R41, R42 |
|
| Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)
|
|
Common Fund Programs, Small Business (SBIR/STTR), Technology Development |
PA-17-147 |
R43, R44 |
|
| Methods to Improve Reproducibility of Human iPSC Derivation, Growth and Differentiation (SBIR) (R44 Clinical Trial Not Allowed)
|
|
Tissue Engineering and Regenerative Medicine |
RFA-GM-19-001 |
R44 |
|
| NIDCR Prospective Observational or Biomarker Clinical Validation Study Cooperative Agreement (U01)
|
|
Clinical Research & Clinical Trials, Epidemiology |
PAR-17-154 |
U01 |
|
| Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01)
|
|
Clinical Research & Clinical Trials, Health Disparities |
PA-17-041 |
R01 |
|
| Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21)
|
|
Clinical Research & Clinical Trials, Health Disparities |
PA-17-042 |
R21 |
|
| Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
|
|
Craniofacial & Dental Development, Disorders, Salivary Biology and Dysfunction |
PA-18-048 |
R21 |
|
| Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Parent Announcements & Trans-NIH Announcements |
RFA-NS-18-046 |
R33, R61 |
|
| Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
RFA-NS-18-041 |
R33, R61 |
|
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
Related Notice
|
|
Parent Announcements & Trans-NIH Announcements, Small Business (SBIR/STTR) |
PA-19-270 |
R41, R42 |
|
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
Related Notice
|
|
Parent Announcements & Trans-NIH Announcements, Small Business (SBIR/STTR) |
PA-19-272 |
R43, R44 |
|
| Administrative Supplements for Research on Dietary Supplements (Admin Supp)
|
|
Parent Announcements & Trans-NIH Announcements |
PA-18-817 |
P30, P40, P50 |
|
